|

FOLFIRINOX Clinical Trials

10 actively recruiting trials across 5 locations

Also known as: Chemotherapy, It is a combination of leucovorin calcium (folinic acid), fluorouracil, irinotecan hydrochloride, and oxaliplatin, leucovorin calcium (folinic acid), fluorouracil, irinotecan hydrochloride, and oxaliplatin., mFolfirinox

Pipeline

Phase 1: 1Phase 2: 4Phase 3: 1Phase 1/2: 3

Top Sponsors

  • University of Louisville1
  • UNC Lineberger Comprehensive Cancer Center1
  • Sun Yat-sen University1
  • Seoul National University Hospital1
  • Phanes Therapeutics1

Indications

  • Cancer10
  • Pancreatic Ductal Adenocarcinoma2
  • Pancreatic Cancer2
  • Ampullary Adenocarcinoma1
  • Gastric or Gastroesophageal Junction Adenocarcinoma1

Other5 trials

NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)
Phase 3
Neoadjuvant FOLFIRINOX in the Treatment of Locally Advanced Gastric Cancer
Phase 2
Neoadjuvant Triple Therapy for (Borderline) Resectable Pancreatic Cancer (PREOPANC-5)
Phase 1/2
The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.
mFOLFIRINOX as Adjuvent Chemotherapy in Treating Chinese Pancreatic Cancer Patients
Phase 2

Duarte, California1 trial

Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)

City of Hope (City of Hope National Medical Center, City of Hope Medical Center)

Phase 1/2

Louisville, Kentucky1 trial

Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma

University of Louisville

Phase 1

New York, New York1 trial

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Icahn School of Medicine at Mount Sinai

Phase 2

Chapel Hill, North Carolina1 trial

Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel

University of North Carolina at Chapel Hill Lineberger Comprehensive Cancer Center

Phase 1/2

Houston, Texas1 trial

Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer

Baylor College of Medicine

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.